Novel methyl indolinone-6-carboxylates containing an indole moiety as angiokinase inhibitors

A novel series of methyl indolinone-6-carboxylates bearing an indole moiety were identified as potent angiokinase inhibitors. The most active compound, A8, potently targeted the kinase activities of vascular endothelial growth factor receptors 2 and 3, and platelet-derived growth factor receptors α and β, with IC₅₀ values in the nanomolar range. In addition, A8 effectively suppressed the proliferation of human umbilical vein endothelial cells, and HT-29 and MCF-7 Cancer cells, by inducing Apoptosis. Compound A8 is thus a promising candidate for further investigation.